Next Article in Journal
Volumetric Bone Mineral Density Measured by HR-pQCT in Patients with Psoriasis or Psoriatic Arthritis: A Systematic Review and Meta-Analysis with Trial Sequential Analysis
Previous Article in Journal
Spatial Disparities in Access to Healthcare Professionals in Sichuan: Evidence from County-Level Data
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Colorimetry-Based Detection of Nitric Oxide from Exhaled Breath for Quantification of Oxidative Stress in Human Body

1
Center for Advanced Materials, Qatar University, Doha 2713, Qatar
2
College of Arts and Science, Qatar University, Doha 2713, Qatar
*
Author to whom correspondence should be addressed.
Healthcare 2021, 9(8), 1055; https://doi.org/10.3390/healthcare9081055
Submission received: 24 June 2021 / Revised: 7 August 2021 / Accepted: 13 August 2021 / Published: 17 August 2021

Abstract

:
Monitoring exhaled breath is a safe, noninvasive method for determining the health status of the human body. Most of the components in our exhaled breath can act as health biomarkers, and they help in providing information about various diseases. Nitric oxide (NO) is one such important biomarker in exhaled breath that indicates oxidative stress in our body. This work presents a simple and noninvasive quantitative analysis approach for detecting NO from exhaled breath. The sensing is based on the colorimetric assisted detection of NO by m-Cresol Purple, Bromophenol Blue, and Alizaringelb dye. The sensing performance of the dye was analyzed by ultraviolet–visible (UV–Vis) spectroscopy. The study covers various sampling conditions like the pH effect, temperature effect, concentration effect, and selective nature of the dye. The m-Cresol Purple dye exhibited a high sensitivity towards NO with a detection limit of ~0.082 ppm in the linear range of 0.002–0.5 ppm. Moreover, the dye apprehended a high degree of selectivity towards other biocompounds present in the breath, and no possible interfering cross-reaction from these species was observed. The dye offered a high sensitivity, selectivity, fast response, and stability, which benchmark its potential for NO sensing. Further, m-Cresol Purple dye is suitable for NO sensing from the exhaled breath and can assist in quantifying oxidative stress levels in the body for the possible detection of COVID-19.

1. Introduction

In the 1980s, Nitric oxide (NO) was discovered as the first endogenously produced gaseous signaling molecule [1]. It is the only endogenous molecule that can act as a neurotransmitter, constructive mediator, inducible mediator, and cytotoxic molecule [2]. The free radical nature of NO is the reason behind its unusual properties and multiple functions [3]. Due to these various physiological roles, the imbalance of NO leads to more than a dozen pathophysiological conditions like hypertension, stroke, cardiac failure, CNS disorder, diabetes mellitus, and many others [4]. There are reports establishing the relation between an increased NO level and bronchial asthma [5,6]. Even the numerous metabolic paths of NO in respiratory pathophysiology have been studied [7]. NO can act as a messenger of various effects like nonadrenergic, noncholinergic neurotransmission, vascular and nonvascular smooth muscle relaxation, etc. [7]. The origin of NO is found in the airway epithelium [8], and its increased level can determine several lung diseases [9]. Thus, NO monitoring devices for diagnosing diseases by noninvasive methods like exhaled breath fingerprinting would be a benchmark [10]. Exhaled breath is a biological medium that carries relevant medical information. The human exhaled breath contains various kinds of VOCs (Volatile Organic Compounds) like NO, CO, CO2, NH3, isopropanol, acetone, etc. that serve as biomarkers for the diagnosis of different diseases [11,12,13]. They originate from normal and metabolic processes occurring in the body. Thus, investigating metabolites in exhaled breath brings out valuable information about malfunctions and subsequent diseases occurring in the human body. Nitric oxide plays a crucial role as an intra- and extracellular mediator in many physiological and pathological processes such as the modulation of vascular tone, thickening and remodeling of the bronchial muscle wall, and regulation of local inflammation [14]. As a result, NO concentration in the exhaled breath is widely studied for the diagnosis of different health conditions such as asthma [15], COPD (Chronic Obstructive Pulmonary Disease) [16], Hypertension, PAH (Pulmonary Arterial Hypertension), and significant conditions like lung diseases [14] and even Covid-19 [17], etc. The NO concentrations in exhaled breath that correspond to different health problems are listed in Table 1.
Recently, Covid-19 diagnosis has been reported by analyzing the VOCs in the exhaled breath using gas chromatography methods like mass spectrometry (GC-MS) and ion mobility spectrometry (GC-IMS) [18]. In humans, a transmembrane protein, angiotensin-converting enzyme 2 (ACE2), serves as the main entry point into cells for the coronavirus family and even COVID-19. ACE2 enzyme is attached to the endothelium and outer surface of cells present in the heart, lungs, intestines, and kidney [19]. The interaction of the coronavirus with ACE2 and endothelium damages their protocol of biological activities and creates an unbalanced metabolism of the cell, often regarded as symptoms of the disease. The prominent nonfunctioning of the endothelium results in the imbalance of reactive oxygen species production [19]. The primary oxygen compound that is greatly affected by the nonfunctioning of the endothelium is NO [19,20]. The imbalance of the NO proportion in the body is directly related to the cause of hypertension [20]. Even in the coronavirus-infected person, the chances of individuals suffering from hypertension are observed, and their death percentage is quite noticeable [20]. Thus, the effective quantification of the NO in the exhaled breath will help distinguish persons infected by the coronavirus and healthy persons.
Various sensing techniques have been reported to diagnose health conditions in accordance with different biomarkers. The most frequently used method for the detection of NO in exhaled breath is a chemiluminescence analyzer [21]. Apart from this, Berkeley NO Test Strips detect NO from saliva [22]. The other techniques used for NO measurements include, colorimetric, fluorometric, electron spin resonance (ESR), electrochemical, etc. [2]. For the real-time application of NO sensors, it is essential to exhibit sensitivity in the range of ppm levels [23,24]. Compared to the other analytical methods, the colorimetric assay has demonstrated great attentiveness due to salient features like simplicity, rapid execution, naked-eye detection, and sensitivity in detecting the analyte concentration in ppm levels. Thus, it is intriguing to study the possibility of measuring NO concentrations using colorimetry, which can lead to the development of noninvasive exhaled breath NO analyzers to diagnose diseases.
In this paper, we report simple dye-based colorimetry sensing to quantify NO levels. For accuracy and stability, the dyes sensing was analyzed at different pH levels and temperature ranges. Moreover, the sensor selectivity towards NO has been verified with respect to other biomarkers present in the exhaled breath.

2. Materials and Methods

2.1. Materials Used

Bromophenol Blue, m-Cresol Purple, and Alizaringelb dyes were purchased from E. Merck, Darmstadt, Germany. Nitric acid (HNO3) (69–72%) was obtained from Research-Lab Fine Chem Industries, Mumbai, India, and Cu wire (R/C 6.35 × 0.61) from Maksal, South Africa. The compounds used for the selectivity analysis are; Ammonia (NH3) (25% from Riedel-de-Haën Germany), Hydrogen peroxide (H2O2) (30% from Meiiorate Health Opc Pvt. Ltd. Mumbai, India), Benzene (C6H6) (99% BDH Ltd. Pool England), C3H8O (>99% from Fluka Chemie, Switzerland), Deionised (DI) water from Millipore Milli-Q water system. All reagents used for analysis were of analytical grade.

2.2. Experimental Methods

The stock solution of Bromophenol Blue, m-Cresol Purple, and Alizaringelb dyes were prepared by dissolving 6 mg of respective dye in 100 mL of DI water. The stock solution of dyes was further diluted three times, and the obtained diluted solution was used in all the experiments. NO gas was prepared by adding 10 g of Cu in 5N HNO3. The resultant reaction byproduct gas, i.e., NO, was bubbled directly into the enclosed bottle containing 200 mL of DI water. After passing the NO, its concentration in the water was estimated by titration with KMnO4. The as-obtained stock solution of NO was further diluted to prepare different concentrations of NO solution ranging from 0.002 ppm to 50 ppm.

2.3. Characterization

A Biochrom UV Spectrophotometer (scanning range; 190–1100 nm) with a scanning range of 300–750 nm was used for ultraviolet–visible (UV–Vis) spectroscopy.

3. Results

3.1. Colorimetry Response of Dye in Different pH

The m-Cresol Purple, Bromophenol Blue, and Alizaringelb dye solutions (10 mL) with pH 2, 4, 6, 7, 9, and 12 were prepared, and 1 mL of 100 ppm NO test solution was added at room temperature. The response time for the dyes was estimated by calculating the time from the addition of NO to the corresponding visible color change observed in the dyes’ solution. Figure 1a shows the m-Cresol Purple detection towards NO in different pH solutions. A significant visible color change was noticed in the pH 12 dye solution. The color change from yellow to orange in the presence of the 100 ppm NO test solution was confirmed by the emergence of a new absorption band centered at ~581 nm in the UV-Vis absorbance spectra, as shown in Figure 1a (left). Figure 1a (right) shows the photograph of the m-Cresol Purple dye solution before and after the addition of the 100 ppm NO test solution. The bare dye solution exhibited a yellow color, and a visible change to orange color was noticed after adding 100 ppm of NO. The estimated response time of m-Cresol Purple dye was ~2 s. For the NO detection analyses performed in Bromophenol Blue dye, a color change was noticed in the pH 12 solution, while no such color change was observed in the acidic and neutral medium. Figure 1b (left) shows the UV–Vis spectra of Bromophenol Blue dye solutions (pH 2–12) after adding 100 ppm of NO test solution. Compared to other pH solutions, an absorption band centered at ~460 nm is observed in UV–Vis spectra of the pH 12 Bromophenol Blue solution. The corresponding visible color change of the dye after adding 100 ppm on NO in pH 12 dye solution is shown in Figure 1b (right). From the figure, a visible color change from blue to yellow is clearly observed. The response time of Bromophenol Blue dye was estimated to be ~5 min. Further, for the NO assay in Alizaringelb solutions with different pH, no significant visible color change was noticed except in the pH 2 solution. The pH 2 solution of Alizaringelb dye turns slightly yellowish after adding 100 ppm of NO, and a corresponding color change is indicated by the emergence of an absorption band centered at ~440 nm in the UV–Vis spectra, as shown in Figure 1c (left). The photograph of the pH 2 Alizaringelb dye solution before and after adding 100 ppm NO is shown in Figure 1c (right). Moreover, the dye apprehended a response time of ~1 min.
Interestingly, compared to the Bromophenol Blue and Alizaringelb dyes’ solution, the NO assay in the m-Cresol Purple dye solution exhibited a noticeable visible color change with a fast response time of ~2 s. Thus, from the above investigation, it can be inferred that the m-Cresol Purple dye is best suited for the colorimetric-based sensing of NO. The observable color change offers a convenient approach to detect NO via unaided eyes. To further elaborate on the sensitivity of the m-Cresol Purple dye towards NO detection, a systematic analysis was carried out by testing different ppm levels of NO in the dye solution.

3.2. Sensitivity Analysis

To analyze the sensitivity of the dye towards NO detection, the UV-Vis study was carried out by varying the NO concentration from 0.002 to 50 ppm in the pH 12 m-Cresol Purple dye solution. Figure 2a shows the UV–Vis absorbance plot of the dye with a change in NO concentration from 0.002–50 ppm. For the absorption peak at 581 nm, an increase in absorbance is observed with an increase in the NO concentration (Figure 2a). The inset in the figure shows the magnified plot of the absorbance peak centered at 581 nm. The corresponding calibration plot for estimating the dye limit of detection (LOD) towards NO sensing is shown in Figure 2b. The calibration curve was plotted by considering the peak absorbance of dye at 581 nm for different concentrations of NO. Linear fitting was performed to estimate the LOD using Equation (1):
LOD =   3 σ m
where m represents the slope of the calibration plot, and σ is the standard deviation of the intercept. Linear fitting was performed in the range of 0.002–0.5 ppm NO, and the estimated LOD was ~0.082 ppm, y = (0.00805 ± 0.8.17 × 10−4)x + (0.124 ± 2.2 × 10−4); R2 = 0.979. The sensitivity investigation indicates that the m-Cresol Purple dyes exhibit a high sensitivity towards NO with a linear detection limit as low as ~0.082 ppm in the concentration range of 0.002–0.5 ppm.

3.3. Temperature Effects

One of the most important properties for sensing applications is the stability of a sensor toward the change in temperature of the surrounding or involved medium. Thus, to investigate the stability of the dye response with respect to change in temperature, the dye solution was subjected to different temperatures, and sensing towards NO was analyzed using UV–Vis absorbance spectroscopy. Figure 3 shows the effect of temperature on the sensing performance of m-Cresol Purple dye (pH 12) towards 5 ppm NO. It is noticeable that the absorbance curve of dye treated with temperatures in the range of 30 °C, 50 °C, and 70 °C exhibits a negligible deviation during NO detection. The temperature study reveals that there is no significant effect of temperature on dye sensing. The above investigation suggests that the colorimetry dye sensor offers a high stability towards the change in temperature, which is very important for getting the real-time NO sensing behavior from the exhaled breath.

3.4. Selectivity

In order to evaluate the selectivity of dye towards NO detection, control experiments were conducted in pH 12 m-Cresol Purple dye solution with potential interfering biomarkers in the breath like H2O2, C6H6, NH3, and C3H8O. The test solution concentration of NO and potential interfering analytes was 5 ppm. Figure 4 shows the comparison of UV–Vis spectra of bare dye solution, dye solution after adding NO, and different analytes. In the case of ammonia, a slight color change was noticed (see Figure 4a). However, the visible blue color was obtained after adding ammonia, which was very distinct from the visible orange color noticed after adding NO to the dye solution. On the other hand, no visible color change was noticed for H2O2, C3H8O, and C6H6. Moreover, after adding different analytes, the UV–Vis study reveals a negligible shift in the absorbance peak centered at ~439 nm, as shown in Figure 4a–d.
Further, m-Cresol Purple dye selectivity for NO was estimated by measuring the shift in the maximum absorption wavelength (Δλ) obtained in the UV–Vis spectra. The peak shift factor is estimated by Equation (2):
Δ λ =   λ   λ 0
where λ and λ0 are the wavelengths of the maximum absorbance measured in the presence of the test analyte and blank dye solution, respectively. The quantitative analysis of the dye selective nature towards NO detection is shown in Figure 5. Compared to other analytes, the addition of NO induces the peak shift that corresponds to the visible color change of m-Cresol Purple dye from yellow to orange. Thus, a significant peak shift is observed for NO compared to the other interfering compounds. The addition of the NO in m-Cresol Purple dye can result in a loss of proton from a phenolic hydroxyl group of the dye molecule, as shown in the inset of Figure 5. The induced loss of proton leads to the formation of a new compound, which is indicated by a dramatic visible color change of the dye solution from a yellow to orange color. These results clearly indicate that other interfering substances showed a negligible competition towards NO detection. Consequently, m-Cresol Purple dye is inert to NO detection and displays a potential towards being a highly selective colorimetric sensor for the NO molecule. As a result, m-Cresol Purple dye appears to be a promising candidate for the noninvasive colorimetry-based detection of NO levels in exhaled breath. It can further assist in quantifying oxidative stress levels in the body.

4. Conclusions

In summary, the systematic investigation of colorimetry sensing of m-Cresol Purple for NO sensing has been presented. The NO sensing performance of the dye was analyzed by the UV–Vis spectroscopy technique. From colorimetry studies, the dye catalyst exhibited a high sensitivity with a detection limit of ~0.082 ppm in the linear range of 0.002–0.5 ppm. The dye also exhibited a high stability with temperature change. The m-Cresol Purple dye shows an outstanding sensitivity, selectivity, fast response, and stability towards the colorimetry-based detection of NO. Moreover, the dye appears to be a promising candidate for the colorimetry-based detection of NO levels in exhaled breath. The noninvasive NO sensor can further be implemented to quantify oxidative stress levels in the body.

Author Contributions

M.R.M., writing—original draft preparation; M.R.M., H.O., H.M., N.-U.-S.R. and M.I. led initial data collection for the main dataset and analyzed the data; A.E.A., R.A., A.A. and F.A. conceived the study described in this paper; P.K. and K.K.S. conceptualization, writing—review, editing, supervision and funding acquisition. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by UREP grant #UREP27-044-3-016 from the Qatar National Research Fund (a member of Qatar Foundation).

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

This work was supported by the UREP grant #UREP27-044-3-016 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Furchgott, R.F.; Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nat. Cell Biol. 1980, 288, 373–376. [Google Scholar] [CrossRef]
  2. Taha, Z.H. Nitric oxide measurements in biological samples. Talanta 2003, 61, 3–10. [Google Scholar] [CrossRef]
  3. Lancaster, J., Jr. (Ed.) Nitric Oxide: Principles and Actions; Elsevier: Amsterdam, The Netherlands, 1996. [Google Scholar]
  4. Ignarro, L.J. (Ed.) Nitric Oxide: Biology and Pathobiology; Academic Press: Cambridge, MA, USA, 2000. [Google Scholar]
  5. Alving, K.; Weitzberg, E.; Lundberg, J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 1993, 6, 1368–1370. [Google Scholar]
  6. Ignarro, L. Nitric Oxide as A Unique Signaling Molecule in the Vascular System: A Historical Overview. J. Physiol. Pharmacol. 2002, 53, 503–514. [Google Scholar]
  7. Ricciardolo, F.L.M. Multiple roles of nitric oxide in the airways. Thorax 2003, 58, 175–182. [Google Scholar] [CrossRef] [Green Version]
  8. Lane, C.; Knight, D.; Burgess, S.; Franklin, P.; Horak, F.; Legg, J.; Moeller, A.; Stick, S. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax 2004, 59, 757–760. [Google Scholar] [CrossRef] [Green Version]
  9. Kharitonov, S.; Barnes, P. Clinical aspects of exhaled nitric oxide. Eur. Respir. J. 2000, 16, 781–792. [Google Scholar] [CrossRef] [Green Version]
  10. Vilar, M.R.; El-Beghdadi, J.; Debontridder, F.; Naaman, R.; Arbel, A.; Ferraria, A.M.; Do Rego, A.B. Development of nitric oxide sensor for asthma attack prevention. Mater. Sci. Eng. C 2006, 26, 253–259. [Google Scholar] [CrossRef]
  11. Das, S.; Pal, M. Review—Non-Invasive Monitoring of Human Health by Exhaled Breath Analysis: A Comprehensive Review. J. Electrochem. Soc. 2020, 167, 037562. [Google Scholar] [CrossRef]
  12. Toma, K.; Tsujii, M.; Arakawa, T.; Iwasaki, Y.; Mitsubayashi, K. Dual-target gas-phase biosensor (bio-sniffer) for assessment of lipid metabolism from breath acetone and isopropanol. Sens. Actuators B Chem. 2020, 329, 129260. [Google Scholar] [CrossRef]
  13. Pan, S.; Tian, Y.; Li, M.; Zhao, J.; Zhu, L.; Zhang, W.; Gu, H.; Wang, H.; Shi, J.; Fang, X.; et al. Quantitative detection of nitric oxide in exhaled human breath by extractive electrospray ionization mass spectrometry. Sci. Rep. 2015, 5, 8725. [Google Scholar] [CrossRef] [Green Version]
  14. Cameli, P.; Bargagli, E.; Bergantini, L.; D’Alessandro, M.; Pieroni, M.; Fontana, G.A.; Sestini, P.; Refini, R.M. Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review. Int. J. Mol. Sci. 2020, 21, 6187. [Google Scholar] [CrossRef] [PubMed]
  15. Cameli, P.; Bergantini, L.; D’Alessandro, M.; Perruzza, M.; Cekorja, B.; Perillo, F.; Massa, E.; Ruzza, A.; Fossi, A.; Beltrami, V.; et al. A Comprehensive Evaluation of Mepolizumab Effectiveness in a Real-Life Setting. Int. Arch. Allergy Immunol. 2020, 181, 606–612. [Google Scholar] [CrossRef] [PubMed]
  16. Malerba, M.; Radaeli, A.; Olivini, A.; Damiani, G.; Ragnoli, B.; Montuschi, P.; Ricciardolo, F.L.M. Exhaled Nitric Oxide as a Biomarker in COPD and Related Comorbidities. BioMed Res. Int. 2014, 2014, 271918. [Google Scholar] [CrossRef] [PubMed]
  17. Possible Correlation: FeNO and COVID-19 by Laura Hughes. Available online: https://www.medicalplasticsnews.com/news/a-possible-correlation-feno-and-covid-19/ (accessed on 15 May 2021).
  18. Gould, O.; Ratcliffe, N.; Król, E.; Costello, B.P.J.D.L. Breath analysis for detection of viral infection, the current position of the field. J. Breath Res. 2020, 14, 041001. [Google Scholar] [CrossRef] [PubMed]
  19. Burgner, D.; Rockett, K.; Kwiatkowski, D. Nitric oxide and infectious diseases. Arch. Dis. Child. 1999, 81, 185–188. [Google Scholar] [CrossRef]
  20. Lei, C.; Su, B.; Dong, H.; Bellavia, A.; Di Fenza, R.; Fakhr, B.S.; Gianni, S.; Grassi, L.G.; Kacmarek, R.; Morais, C.C.A.; et al. Protocol of a randomized con-trolled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2). medRxiv 2020. [Google Scholar] [CrossRef] [Green Version]
  21. Fontijn, A.; Sabadell, A.J.; Ronco, R.J. Homogeneous chemiluminescent measurement of nitric oxide with ozone. Implications for continuous selective monitoring of gaseous air pollutants. Anal. Chem. 1970, 42, 575–579. [Google Scholar] [CrossRef]
  22. Babateen, A.M.; Shannon, O.M.; Mathers, J.C.; Siervo, M. Validity and reliability of test strips for the meas-urement of salivary nitrite concentration with and without the use of mouthwash in healthy adults. Nitric Oxide 2019, 91, 15–22. [Google Scholar] [CrossRef]
  23. Fruhberger, B.; Stirling, N.; Grillo, F.G.; Ma, S.; Ruthven, D.; Lad, R.J.; Frederick, B.G. Detection and quanti-fication of nitric oxide in human breath using a semiconducting oxide based chemiresistive microsensor. Sens. Actuators B Chem. 2001, 76, 226–234. [Google Scholar] [CrossRef]
  24. Mondal, S.P.; Dutta, P.K.; Hunter, G.; Ward, B.; Laskowski, D.; Dweik, R. Development of high sensitivity potentiometric NOx sensor and its application to breath analysis. Sens. Actuators B Chem. 2011, 158, 292–298. [Google Scholar] [CrossRef]
Figure 1. The effect of NO at different pH levels of dyes’ solutions. (a) UV–Vis spectra of m-Cresol Purple dye solutions after adding 100 ppm of NO (left) along with a photograph of the dye solution (right). (b) UV–Vis spectra of Bromophenol Blue dye solutions after adding 100 ppm of NO (left) along with a photograph of the dye solution (right). (c) UV–Vis spectra of Alizaringelb dye solutions after adding 100 ppm of NO (left) along with a photograph of the dye solution (right).
Figure 1. The effect of NO at different pH levels of dyes’ solutions. (a) UV–Vis spectra of m-Cresol Purple dye solutions after adding 100 ppm of NO (left) along with a photograph of the dye solution (right). (b) UV–Vis spectra of Bromophenol Blue dye solutions after adding 100 ppm of NO (left) along with a photograph of the dye solution (right). (c) UV–Vis spectra of Alizaringelb dye solutions after adding 100 ppm of NO (left) along with a photograph of the dye solution (right).
Healthcare 09 01055 g001
Figure 2. m-Cresol Purple dye sensitivity towards NO detection. (a) UV–Vis absorption curve of dye with change in NO concentration. Inset shows the magnified plot of the absorbance peak centered at 581 nm. (b) Corresponding calibration plot of dye in the detection range of 0.002–0.5 ppm.
Figure 2. m-Cresol Purple dye sensitivity towards NO detection. (a) UV–Vis absorption curve of dye with change in NO concentration. Inset shows the magnified plot of the absorbance peak centered at 581 nm. (b) Corresponding calibration plot of dye in the detection range of 0.002–0.5 ppm.
Healthcare 09 01055 g002
Figure 3. The UV–Vis absorbance plot of m-Cresol Purple dye after adding 5 ppm of NO at different temperatures.
Figure 3. The UV–Vis absorbance plot of m-Cresol Purple dye after adding 5 ppm of NO at different temperatures.
Healthcare 09 01055 g003
Figure 4. Selectivity analysis of m-Cresol Purple dye. (a) Ammonia. (b) Hydrogen peroxide. (c) Isopropyl alcohol. (d) Benzene.
Figure 4. Selectivity analysis of m-Cresol Purple dye. (a) Ammonia. (b) Hydrogen peroxide. (c) Isopropyl alcohol. (d) Benzene.
Healthcare 09 01055 g004
Figure 5. Selectivity analysis of m-Cresol Purple dye towards NO and other analytes.
Figure 5. Selectivity analysis of m-Cresol Purple dye towards NO and other analytes.
Healthcare 09 01055 g005
Table 1. NO concentration in exhaled breath for different health conditions.
Table 1. NO concentration in exhaled breath for different health conditions.
Disease/ConditionNO Level
Covid 19≤15 ppb
Asthma>45 ppb
Severe COPD<10 ppb
PAH<10 ppb
Heart failure>20 ppb
Atherosclerosis<10 ppb
Psoriasis>20 ppb
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Maurya, M.R.; Onthath, H.; Morsy, H.; Riyaz, N.-U.-S.; Ibrahim, M.; Ahmed, A.E.; Abuznad, R.; Alruwaili, A.; Alsaedi, F.; Kasak, P.; et al. Colorimetry-Based Detection of Nitric Oxide from Exhaled Breath for Quantification of Oxidative Stress in Human Body. Healthcare 2021, 9, 1055. https://doi.org/10.3390/healthcare9081055

AMA Style

Maurya MR, Onthath H, Morsy H, Riyaz N-U-S, Ibrahim M, Ahmed AE, Abuznad R, Alruwaili A, Alsaedi F, Kasak P, et al. Colorimetry-Based Detection of Nitric Oxide from Exhaled Breath for Quantification of Oxidative Stress in Human Body. Healthcare. 2021; 9(8):1055. https://doi.org/10.3390/healthcare9081055

Chicago/Turabian Style

Maurya, Muni Raj, Haseena Onthath, Hagar Morsy, Najam-US-Sahar Riyaz, Muna Ibrahim, Alaa Elsafi Ahmed, Raghad Abuznad, Aeshah Alruwaili, Fatimatulzahraa Alsaedi, Peter Kasak, and et al. 2021. "Colorimetry-Based Detection of Nitric Oxide from Exhaled Breath for Quantification of Oxidative Stress in Human Body" Healthcare 9, no. 8: 1055. https://doi.org/10.3390/healthcare9081055

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop